Delivery Order SPE2DE23D0008-SPE2D626F983F
- Not listed
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a $4,014 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain division for Natrelle Inspira SCF 605CC breast implants. The contract is a fixed-price delivery order with economic price adjustment clause, with a completion date of September 4, 2025. The place of performance is located in Irvine, California. This award was made without a set-aside designation, reflecting Allergan's position as a specialized...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $2,814.00 by the Defense Logistics Agency's Medical Supply Chain division on July 22, 2025, with an ultimate completion date of July 24, 2025. The contract covers the supply of Natrelle Inspira SCM 375CC breast implants and will be performed in Irvine, California. This award was made without set-aside designation, reflecting Allergan's position as a specialized supplier of these medical devices to federal...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,614.00 fixed-price delivery order on September 19, 2025, for Natrelle Inspira SCM 445CC breast implants through the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The contract carries an ultimate completion date of September 23, 2025, and will be performed in Irvine, California. This delivery order was issued without set-aside designation, reflecting Allergan's sole-source supplier status for specialized...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 fixed-price delivery order with economic price adjustment on September 2, 2025, for Natrelle Inspira SCM 375CC breast implants. The contract, which carries an ultimate completion date of September 4, 2025, was funded by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation, reflecting Allergan's status as a sole-source provider of specialized surgical medical devices. The place of...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,850 fixed-price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical on November 6, 2025, for Natrelle Inspira SSM 405CC breast implants. The contract, which represents a child delivery order under a larger Indefinite Delivery Vehicle (IDV), is scheduled for completion by November 24, 2025, and will be performed at the contractor's facility in Irvine, California. The award carries no set-aside designation,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $3,021.00 fixed-price delivery order with economic price adjustment for Natrelle Inspira SCM 375CC breast implants on July 22, 2025. This delivery order, which is a child contract under a larger Indefinite Delivery Vehicle, will be performed in Irvine, California and is scheduled for completion by July 24, 2025. The contract was awarded without set-aside designation by the Medical Supply Chain division of the Defense Logistics...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $3,228.00 fixed-price delivery order with economic price adjustment on December 9, 2025, for Natrelle Inspira SCF 385CC breast implants. The contract, which is expected to be completed by December 11, 2025, will be performed at Allergan's facility in Irvine, California. This delivery order carries no set-aside designation and is funded through the Medical Supply Chain division of the Defense Logistics Agency (DLA) Troop Support...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a $2,850 delivery order by the Defense Logistics Agency's Medical Supply Chain division for Natrelle Inspira SSM 310CC breast implants. The fixed-price contract with economic price adjustment carries an ultimate completion date of December 15, 2025, and represents a child delivery order under one of Allergan's two significant indefinite delivery vehicle agreements established with DLA Troop Support Medical in December 2022. The...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $3,300 fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division on December 11, 2025, for Natrelle Inspira SSM 520CC breast implants. The delivery order, which carries no set-aside designation, is scheduled for completion by December 24, 2025, with performance occurring at the company's facility in Irvine, California. This award represents a child contract under one of Allergan's larger Indefinite...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,814.00 fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on November 18, 2025, for Natrelle Inspira SCX 750cc breast implants. The contract, which carries no set-aside designation, is classified as a child order under a larger Indefinite Delivery Vehicle and reflects Allergan's status as a sole-source provider of specialized surgical devices to federal healthcare systems. The delivery order is set to...
- SPE2DE23D0008Indefinite Delivery Contract
- SPE2DE23D0008-SPE2D626F983FDelivery Order
Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a $2,814 delivery order for Natrelle Inspira SCF 485CC breast implants by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment was awarded on December 9, 2025, with an ultimate completion date of December 11, 2025, and will be performed in Irvine, California. The award was made without a set-aside designation, reflecting Allergan's status as the sole-source provider of these specialized medical devices to federal healthcare systems. This delivery order represents a task issued under Allergan's existing Indefinite Delivery/Indefinite Quantity contracts with DLA Troop Support Medical, including the $13.5 million IDV for Natrelle breast implants and surgical devices established in December 2022. The implants procured through this order will support reconstructive and aesthetic surgical procedures across Department of Defense treatment facilities, veterans' hospitals, and Indian Health Service centers, ensuring the availability of specialized medical products for military members, veterans, and Native American populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 12/8/25 |